A new Food and Drug Administration AI tool that could speed up reviews and approvals of medical devices such as pacemakers ...

AI-driven Clairity Breast platform, now FDA-approved, predicts five-year breast cancer risk from mammograms, enhancing early ...

The FDA launched an artificial intelligence tool Monday dubbed Elsa, with Commissioner Marty Makary hyping the effort’s early ...

Alex Ratner, CEO of Snorkel AI, remembers a time when data labeling —the grueling task of adding context to swathes of raw ...

The U.S. Food and Drug Administration said on Monday that it had launched a generative AI tool, Elsa, aimed at improving ...

The FDA has launched the generative AI tool, Elsa, agency-wide to help its employees with everything from clinical reviews to ...

The FDA granted de novo authorization to the first artificial intelligence (AI) program to support breast cancer risk ...

The FDA launched Elsa, its first generative AI tool, to streamline reviews and modernize agency workflow across all centers.

The FDA may be facing a 4% cut to its overall budget courtesy of the Trump administration, but that hasn’t stopped the agency ...

The FDA launches Elsa, an AI tool, to modernize operations like scientific reviews and drug approvals. Read more here.

Following a successful pilot, the Food and Drug Administration unveiled its in-house large language model designed to help ...